An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia

Mise à jour : Il y a 4 ans
Référence : NCT01245530

Femme et Homme

Extrait

The purpose of this study is to evaluate the efficacy and safety of two fixed dose (1200mg/day, 1600mg/day) of INM-176 (a drug of treating dementia) comparing with donepezil for treatment for patients with Alzheimer type dementia.


Critère d'inclusion

  • Alzheimer Type Dementia

Liens